{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:35Z","timestamp":1792783415138,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQN25H020019"],"award-info":[{"award-number":["LQN25H020019"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12265-026-10858-5","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:01:19Z","timestamp":1791478879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["YAP and WWTR1\/TAZ Connect Mechanotransduction and Mitochondrial Metabolism in Cardiac Hypertrophy and Ventricular Remodeling"],"prefix":"10.1007","volume":"19","author":[{"given":"Feihu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimiao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huashan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-5450","authenticated-orcid":false,"given":"Changjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"10858_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","volume":"135","author":"A Hinton Jr","year":"2024","unstructured":"Hinton A Jr, Claypool SM, Neikirk K, Senoo N, Wanjalla CN, Kirabo A, et al. Mitochondrial structure and function in human heart failure. Circ Res. 2024;135:372\u201396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323800.","journal-title":"Circ Res"},{"key":"10858_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487\u2013513. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318241.","journal-title":"Circ Res"},{"key":"10858_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yjmcc.2012.09.002","volume":"55","author":"MG Rosca","year":"2013","unstructured":"Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2013;55:31\u201341. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.09.002.","journal-title":"J Mol Cell Cardiol"},{"key":"10858_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-3-319-55330-6_11","volume":"982","author":"HTF Facundo","year":"2017","unstructured":"Facundo HTF, Brainard RE, Caldas FRL, Lucas AMB. Mitochondria and cardiac hypertrophy. Adv Exp Med Biol. 2017;982:203\u201326. https:\/\/doi.org\/10.1007\/978-3-319-55330-6_11.","journal-title":"Adv Exp Med Biol"},{"key":"10858_CR5","doi-asserted-by":"publisher","first-page":"100489","DOI":"10.1016\/j.cophys.2022.100489","volume":"25","author":"MP Lazaropoulos","year":"2022","unstructured":"Lazaropoulos MP, Elrod JW. Mitochondria in pathological cardiac remodeling. Curr Opin Physiol. 2022;25:100489. https:\/\/doi.org\/10.1016\/j.cophys.2022.100489.","journal-title":"Curr Opin Physiol"},{"key":"10858_CR6","doi-asserted-by":"publisher","first-page":"822969","DOI":"10.3389\/fcvm.2021.822969","volume":"8","author":"D Yang","year":"2022","unstructured":"Yang D, Liu HQ, Liu FY, Guo Z, An P, Wang MY, et al. Mitochondria in pathological cardiac hypertrophy research and therapy. Front Cardiovasc Med. 2022;8:822969. https:\/\/doi.org\/10.3389\/fcvm.2021.822969.","journal-title":"Front Cardiovasc Med"},{"key":"10858_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20517\/jca.2022.42","volume":"3","author":"B Werbner","year":"2023","unstructured":"Werbner B, Tavakoli-Rouzbehani OM, Fatahian AN, Boudina S. The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure. J Cardiovasc Aging. 2023;3:9. https:\/\/doi.org\/10.20517\/jca.2022.42.","journal-title":"J Cardiovasc Aging"},{"key":"10858_CR8","doi-asserted-by":"publisher","first-page":"101345","DOI":"10.1016\/j.jacbts.2025.101345","volume":"10","author":"AM Parker","year":"2025","unstructured":"Parker AM, Lees JG, Murray AJ, Velagic A, Ritchie RH. Precision medicine: therapeutically targeting mitochondrial alterations in heart failure. JACC Basic Transl Sci. 2025;10:101345. https:\/\/doi.org\/10.1016\/j.jacbts.2025.101345.","journal-title":"JACC Basic Transl Sci"},{"key":"10858_CR9","doi-asserted-by":"publisher","first-page":"H1267","DOI":"10.1152\/ajpheart.00121.2025","volume":"328","author":"LA Shehadeh","year":"2025","unstructured":"Shehadeh LA, Robleto E, Lopaschuk GD. Cardiac energy substrate utilization in heart failure with preserved ejection fraction: reconciling conflicting evidence on fatty acid and glucose metabolism. Am J Physiol Heart Circ Physiol. 2025;328:H1267\u201395. https:\/\/doi.org\/10.1152\/ajpheart.00121.2025.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10858_CR10","doi-asserted-by":"publisher","first-page":"1290046","DOI":"10.3389\/fcell.2023.1290046","volume":"11","author":"AE Atici","year":"2023","unstructured":"Atici AE, Crother TR, Noval Rivas M. Mitochondrial quality control in health and cardiovascular diseases. Front Cell Dev Biol. 2023;11:1290046. https:\/\/doi.org\/10.3389\/fcell.2023.1290046.","journal-title":"Front Cell Dev Biol"},{"key":"10858_CR11","doi-asserted-by":"publisher","first-page":"H89","DOI":"10.1152\/ajpheart.00732.2019","volume":"319","author":"R Liu","year":"2020","unstructured":"Liu R, Jagannathan R, Sun L, Li F, Yang P, Lee J, et al. Tead1 is essential for mitochondrial function in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2020;319:H89\u201399. https:\/\/doi.org\/10.1152\/ajpheart.00732.2019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10858_CR12","doi-asserted-by":"publisher","first-page":"e150595","DOI":"10.1172\/JCI150595","volume":"132","author":"T Kashihara","year":"2022","unstructured":"Kashihara T, Mukai R, Oka SI, Zhai P, Nakada Y, Yang Z, et al. YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload. J Clin Invest. 2022;132:e150595. https:\/\/doi.org\/10.1172\/JCI150595.","journal-title":"J Clin Invest"},{"key":"10858_CR13","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.7150\/thno.74563","volume":"12","author":"P Yue","year":"2022","unstructured":"Yue P, Zhang Y, Liu L, Zhou K, Xia S, Peng M, et al. Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload. Theranostics. 2022;12:7009\u201331. https:\/\/doi.org\/10.7150\/thno.74563.","journal-title":"Theranostics"},{"key":"10858_CR14","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1074\/jbc.RA118.006123","volume":"294","author":"J Byun","year":"2019","unstructured":"Byun J, Del Re DP, Zhai P, Ikeda S, Shirakabe A, Mizushima W, et al. Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload. J Biol Chem. 2019;294:3603\u201317. https:\/\/doi.org\/10.1074\/jbc.RA118.006123.","journal-title":"J Biol Chem"},{"key":"10858_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacbts.2020.07.009","volume":"5","author":"J Francisco","year":"2020","unstructured":"Francisco J, Zhang Y, Jeong JI, Mizushima W, Ikeda S, Ivessa A, et al. Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition. JACC Basic Transl Sci. 2020;5:931\u201345. https:\/\/doi.org\/10.1016\/j.jacbts.2020.07.009.","journal-title":"JACC Basic Transl Sci"},{"key":"10858_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/cvr\/cvab205","volume":"118","author":"MM Mia","year":"2022","unstructured":"Mia MM, Cibi DM, Ghani SA, Singh A, Tee N, Sivakumar V, et al. Loss of Yap\/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Cardiovasc Res. 2022;118:1785\u2013804. https:\/\/doi.org\/10.1093\/cvr\/cvab205.","journal-title":"Cardiovasc Res"},{"key":"10858_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI90149","volume":"127","author":"V Ramjee","year":"2017","unstructured":"Ramjee V, Li D, Manderfield LJ, Liu F, Engleka KA, Aghajanian H, et al. Epicardial YAP\/TAZ orchestrate an immunosuppressive response following myocardial infarction. J Clin Invest. 2017;127:899\u2013911. https:\/\/doi.org\/10.1172\/JCI90149.","journal-title":"J Clin Invest"},{"key":"10858_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mvr.2018.04.003","volume":"119","author":"A Mammoto","year":"2018","unstructured":"Mammoto A, Muyleart M, Kadlec A, Gutterman D, Mammoto T. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1alpha. Microvasc Res. 2018;119:73\u201383. https:\/\/doi.org\/10.1016\/j.mvr.2018.04.003.","journal-title":"Microvasc Res"},{"key":"10858_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nature20602","volume":"540","author":"L Wang","year":"2016","unstructured":"Wang L, Luo JY, Li B, Tian XY, Chen LJ, Huang Y, et al. Integrin-YAP\/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Nature. 2016;540:579\u201382. https:\/\/doi.org\/10.1038\/nature20602.","journal-title":"Nature"},{"key":"10858_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fphys.2018.00382","volume":"9","author":"VFM Segers","year":"2018","unstructured":"Segers VFM, De Keulenaer GW. Cardiac remodeling: endothelial cells have more to say than just NO. Front Physiol. 2018;9:382. https:\/\/doi.org\/10.3389\/fphys.2018.00382.","journal-title":"Front Physiol"},{"key":"10858_CR21","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The biology of YAP\/TAZ: Hippo signaling and beyond. Physiol Rev. 2014;94:1287\u2013312. https:\/\/doi.org\/10.1152\/physrev.00005.2014.","journal-title":"Physiol Rev"},{"key":"10858_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan KL. The Hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111829.","journal-title":"Annu Rev Biochem"},{"key":"10858_CR23","doi-asserted-by":"publisher","first-page":"jcs230425","DOI":"10.1242\/jcs230425","volume":"133","author":"A Pocaterra","year":"2020","unstructured":"Pocaterra A, Romani P, Dupont S. YAP\/TAZ functions and their regulation at a glance. J Cell Sci. 2020;133:jcs230425. https:\/\/doi.org\/10.1242\/jcs230425.","journal-title":"J Cell Sci"},{"key":"10858_CR24","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1101\/gad.888601","volume":"15","author":"A Vassilev","year":"2001","unstructured":"Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. TEAD\/TEF transcription factors utilize the activation domain of YAP65, a Src\/Yes-associated protein localized in the cytoplasm. Genes Dev. 2001;15:1229\u201341. https:\/\/doi.org\/10.1101\/gad.888601.","journal-title":"Genes Dev"},{"key":"10858_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","volume":"28","author":"JH Koo","year":"2018","unstructured":"Koo JH, Guan KL. Interplay between YAP\/TAZ and metabolism. Cell Metab. 2018;28:196\u2013206. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.010.","journal-title":"Cell Metab"},{"key":"10858_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.devcel.2020.06.025","volume":"54","author":"C Ibar","year":"2020","unstructured":"Ibar C, Irvine KD. Integration of Hippo-YAP signaling with metabolism. Dev Cell. 2020;54:256\u201367. https:\/\/doi.org\/10.1016\/j.devcel.2020.06.025.","journal-title":"Dev Cell"},{"key":"10858_CR27","doi-asserted-by":"publisher","first-page":"1021823","DOI":"10.3389\/fonc.2022.1021823","volume":"12","author":"A Gridnev","year":"2022","unstructured":"Gridnev A, Mendiola M, Seto E, LoRusso PM. Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. Front Oncol. 2022;12:1021823. https:\/\/doi.org\/10.3389\/fonc.2022.1021823.","journal-title":"Front Oncol"},{"key":"10858_CR28","doi-asserted-by":"publisher","first-page":"e18330","DOI":"10.1111\/jcmm.18330","volume":"28","author":"KA Papavassiliou","year":"2024","unstructured":"Papavassiliou KA, Papavassiliou AG. YAP\/TAZ-TEAD signalling axis: drugging the undruggable. J Cell Mol Med. 2024;28:e18330. https:\/\/doi.org\/10.1111\/jcmm.18330.","journal-title":"J Cell Mol Med"},{"key":"10858_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF-beta-TrCP. Genes Dev. 2010;24:72\u201385. https:\/\/doi.org\/10.1101\/gad.1843810.","journal-title":"Genes Dev"},{"key":"10858_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.devcel.2013.05.025","volume":"26","author":"MJ Oudhoff","year":"2013","unstructured":"Oudhoff MJ, Freeman SA, Couzens AL, Antignano F, Kuznetsova E, Min PH, et al. Control of the Hippo pathway by Set7-dependent methylation of Yap. Dev Cell. 2013;26:188\u201394. https:\/\/doi.org\/10.1016\/j.devcel.2013.05.025.","journal-title":"Dev Cell"},{"key":"10858_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nchembio.2036","volume":"12","author":"P Chan","year":"2016","unstructured":"Chan P, Han X, Zheng B, DeRan M, Yu J, Jarugumilli GK, et al. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway. Nat Chem Biol. 2016;12:282\u20139. https:\/\/doi.org\/10.1038\/nchembio.2036.","journal-title":"Nat Chem Biol"},{"key":"10858_CR32","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1073\/pnas.1313192110","volume":"110","author":"M Xin","year":"2013","unstructured":"Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A. 2013;110:13839\u201344. https:\/\/doi.org\/10.1073\/pnas.1313192110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10858_CR33","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1101\/gad.269894.115","volume":"29","author":"GW Dorn","year":"2015","unstructured":"Dorn GW 2nd, Vega RB, Kelly DP. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev. 2015;29:1981\u201391. https:\/\/doi.org\/10.1101\/gad.269894.115.","journal-title":"Genes Dev"},{"key":"10858_CR34","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.3390\/ijms24043414","volume":"24","author":"G Morciano","year":"2023","unstructured":"Morciano G, Boncompagni C, Ramaccini D, Pedriali G, Bouhamida E, Tremoli E, et al. Comprehensive analysis of mitochondrial dynamics alterations in heart diseases. Int J Mol Sci. 2023;24:3414. https:\/\/doi.org\/10.3390\/ijms24043414.","journal-title":"Int J Mol Sci"},{"key":"10858_CR35","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3390\/genes14101876","volume":"14","author":"T Tokuyama","year":"2023","unstructured":"Tokuyama T, Yanagi S. Role of mitochondrial dynamics in heart diseases. Genes. 2023;14:1876. https:\/\/doi.org\/10.3390\/genes14101876.","journal-title":"Genes"},{"key":"10858_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.omtn.2021.06.006","volume":"25","author":"LHH Aung","year":"2021","unstructured":"Aung LHH, Jumbo JCC, Wang Y, Li P. Therapeutic potential and recent advances on targeting mitochondrial dynamics in cardiac hypertrophy: a concise review. Mol Ther Nucleic Acids. 2021;25:416\u201343. https:\/\/doi.org\/10.1016\/j.omtn.2021.06.006.","journal-title":"Mol Ther Nucleic Acids"},{"key":"10858_CR37","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/s41467-025-60670-z","volume":"16","author":"N Sun","year":"2025","unstructured":"Sun N, Zhu Q, Combs ME, Liu J, Bai X, Wang WB, et al. Mitophagy mitigates mitochondrial fatty acid beta-oxidation deficient cardiomyopathy. Nat Commun. 2025;16:5551. https:\/\/doi.org\/10.1038\/s41467-025-60670-z.","journal-title":"Nat Commun"},{"key":"10858_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","volume":"123","author":"AA Gibb","year":"2018","unstructured":"Gibb AA, Hill BG. Metabolic coordination of physiological and pathological cardiac remodeling. Circ Res. 2018;123:107\u201328. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312017.","journal-title":"Circ Res"},{"key":"10858_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/ijms23020996","volume":"23","author":"T Yamamoto","year":"2022","unstructured":"Yamamoto T, Sano M. Deranged myocardial fatty acid metabolism in heart failure. Int J Mol Sci. 2022;23:996. https:\/\/doi.org\/10.3390\/ijms23020996.","journal-title":"Int J Mol Sci"},{"key":"10858_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, et al. Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14:238\u201350. https:\/\/doi.org\/10.1038\/nrcardio.2016.203.","journal-title":"Nat Rev Cardiol"},{"key":"10858_CR41","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1074\/jbc.M310292200","volume":"279","author":"JR McMullen","year":"2004","unstructured":"McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110alpha) pathway. J Biol Chem. 2004;279:4782\u201393. https:\/\/doi.org\/10.1074\/jbc.M310292200.","journal-title":"J Biol Chem"},{"key":"10858_CR42","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1210\/me.2008-0265","volume":"22","author":"J Kim","year":"2008","unstructured":"Kim J, Wende AR, Sena S, Theobald HA, Soto J, Sloan C, et al. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol. 2008;22:2531\u201343. https:\/\/doi.org\/10.1210\/me.2008-0265.","journal-title":"Mol Endocrinol"},{"key":"10858_CR43","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/cells8101128","volume":"8","author":"D Schuttler","year":"2019","unstructured":"Schuttler D, Clauss S, Weckbach LT, Brunner S. Molecular mechanisms of cardiac remodeling and regeneration in physical exercise. Cells. 2019;8:1128. https:\/\/doi.org\/10.3390\/cells8101128.","journal-title":"Cells"},{"key":"10858_CR44","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.mbm.2024.100085","volume":"2","author":"R Islam","year":"2024","unstructured":"Islam R, Hong Z. YAP\/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis. Mechanobiol Med. 2024;2:100085. https:\/\/doi.org\/10.1016\/j.mbm.2024.100085.","journal-title":"Mechanobiol Med"},{"key":"10858_CR45","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1253\/circj.CJ-16-0426","volume":"80","author":"DP Del Re","year":"2016","unstructured":"Del Re DP. Hippo signaling in the heart: non-canonical pathways impact growth, survival, and function. Circ J. 2016;80:1504\u201310. https:\/\/doi.org\/10.1253\/circj.CJ-16-0426.","journal-title":"Circ J"},{"key":"10858_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fcell.2019.00211","volume":"7","author":"MM Mia","year":"2019","unstructured":"Mia MM, Singh MK. The Hippo signaling pathway in cardiac development and diseases. Front Cell Dev Biol. 2019;7:211. https:\/\/doi.org\/10.3389\/fcell.2019.00211.","journal-title":"Front Cell Dev Biol"},{"key":"10858_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/FJC.0000000000000736","volume":"74","author":"T Kashihara","year":"2019","unstructured":"Kashihara T, Sadoshima J. The role of YAP\/TAZ in energy metabolism in the heart. J Cardiovasc Pharmacol. 2019;74:483\u201390. https:\/\/doi.org\/10.1097\/FJC.0000000000000736.","journal-title":"J Cardiovasc Pharmacol"},{"key":"10858_CR48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jjcc.2024.01.002","volume":"83","author":"T Kashihara","year":"2024","unstructured":"Kashihara T, Sadoshima J. Regulation of myocardial glucose metabolism by YAP\/TAZ signaling. J Cardiol. 2024;83:323\u20139. https:\/\/doi.org\/10.1016\/j.jjcc.2024.01.002.","journal-title":"J Cardiol"},{"key":"10858_CR49","doi-asserted-by":"publisher","first-page":"e157664","DOI":"10.1172\/JCI157664","volume":"132","author":"C Gao","year":"2022","unstructured":"Gao C, Wang Y. YAP: the nexus between metabolism and cardiac remodeling. J Clin Invest. 2022;132:e157664. https:\/\/doi.org\/10.1172\/JCI157664.","journal-title":"J Clin Invest"},{"key":"10858_CR50","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/med.21733","volume":"41","author":"X Wu","year":"2021","unstructured":"Wu X, Liu Z, Yu XY, Xu S, Luo J. Autophagy and cardiac diseases: therapeutic potential of natural products. Med Res Rev. 2021;41:314\u201341. https:\/\/doi.org\/10.1002\/med.21733.","journal-title":"Med Res Rev"},{"key":"10858_CR51","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41419-020-03087-0","volume":"11","author":"D Wang","year":"2020","unstructured":"Wang D, He J, Huang B, Liu S, Zhu H, Xu T. Emerging role of the Hippo pathway in autophagy. Cell Death Dis. 2020;11:880. https:\/\/doi.org\/10.1038\/s41419-020-03087-0.","journal-title":"Cell Death Dis"},{"key":"10858_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.celrep.2014.09.036","volume":"9","author":"M DeRan","year":"2014","unstructured":"DeRan M, Yang J, Shen CH, Peters EC, Fitamant J, Chan P, et al. Energy stress regulates Hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 2014;9:495\u2013503. https:\/\/doi.org\/10.1016\/j.celrep.2014.09.036.","journal-title":"Cell Rep"},{"key":"10858_CR53","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ncb3111","volume":"17","author":"JS Mo","year":"2015","unstructured":"Mo JS, Meng Z, Kim YC, Park HW, Hansen CG, Kim S, et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17:500\u201310. https:\/\/doi.org\/10.1038\/ncb3111.","journal-title":"Nat Cell Biol"},{"key":"10858_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1101\/gad.173435.111","volume":"26","author":"B Zhao","year":"2012","unstructured":"Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012;26:54\u201368. https:\/\/doi.org\/10.1101\/gad.173435.111.","journal-title":"Genes Dev"},{"key":"10858_CR55","doi-asserted-by":"publisher","first-page":"e143173","DOI":"10.1172\/JCI143173","volume":"131","author":"S Ikeda","year":"2021","unstructured":"Ikeda S, Nah J, Shirakabe A, Zhai P, Oka SI, Sciarretta S, et al. YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases. J Clin Invest. 2021;131:e143173. https:\/\/doi.org\/10.1172\/JCI143173.","journal-title":"J Clin Invest"},{"key":"10858_CR56","doi-asserted-by":"publisher","first-page":"103597","DOI":"10.1016\/j.redox.2025.103597","volume":"82","author":"G She","year":"2025","unstructured":"She G, Hai H, Zhang Y, Li X, Wang C, Zhang H. Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1. Redox Biol. 2025;82:103597. https:\/\/doi.org\/10.1016\/j.redox.2025.103597.","journal-title":"Redox Biol"},{"key":"10858_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1253\/circj.CJ-24-0171","volume":"89","author":"C Hu","year":"2024","unstructured":"Hu C, Francisco J, Del Re DP, Sadoshima J. Decoding the impact of the Hippo pathway on different cell types in heart failure. Circ J. 2024;89:6\u201315. https:\/\/doi.org\/10.1253\/circj.CJ-24-0171.","journal-title":"Circ J"},{"key":"10858_CR58","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","volume":"332","author":"T Heallen","year":"2011","unstructured":"Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332:458\u201361. https:\/\/doi.org\/10.1126\/science.1199010.","journal-title":"Science"},{"key":"10858_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCRESAHA.115.304457","volume":"116","author":"Z Lin","year":"2015","unstructured":"Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, et al. Pi3kcb links Hippo-YAP and PI3K-Akt signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015;116:35\u201345. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.304457.","journal-title":"Circ Res"},{"key":"10858_CR60","doi-asserted-by":"publisher","first-page":"ra70","DOI":"10.1126\/scisignal.2002278","volume":"4","author":"M Xin","year":"2011","unstructured":"Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, Schwartz RJ, et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal. 2011;4:ra70. https:\/\/doi.org\/10.1126\/scisignal.2002278.","journal-title":"Sci Signal"},{"key":"10858_CR61","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","volume":"31","author":"TA Yap","year":"2025","unstructured":"Yap TA, Kwiatkowski DJ, Dagogo-Jack I, Offin M, Zauderer MG, Kratzke R, et al. YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial. Nat Med. 2025;31:4281\u201390. https:\/\/doi.org\/10.1038\/s41591-025-04029-3.","journal-title":"Nat Med"},{"key":"10858_CR62","unstructured":"ClinicalTrials.gov. Study to evaluate VT3989 in patients with metastatic solid tumors. NCT04665206. Updated April 2, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04665206.\u00a0 Accessed 16 Sept 2026."},{"key":"10858_CR63","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","volume":"5","author":"EA Chapeau","year":"2024","unstructured":"Chapeau EA, Sansregret L, Galli GG, Chene P, Wartmann M, Mourikis TP, et al. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer. 2024;5:1102\u201320. https:\/\/doi.org\/10.1038\/s43018-024-00754-9.","journal-title":"Nat Cancer"},{"key":"10858_CR64","unstructured":"ClinicalTrials.gov. A phase I study of IAG933 in patients with advanced mesothelioma and other solid tumors. NCT04857372. Updated June 22, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04857372.\u00a0 Accessed 16 Sept 2026."},{"key":"10858_CR65","unstructured":"ClinicalTrials.gov. Oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors. NCT05228015. https:\/\/clinicaltrials.gov\/study\/NCT05228015. Accessed 16 Sept 2026."},{"key":"10858_CR66","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2131\/jts.49.175","volume":"49","author":"H Otsuki","year":"2024","unstructured":"Otsuki H, Fujimoto N, Nakayama Y, et al. Pathological characterization of reversible proteinuria induced by the TEAD inhibitor K-975 in rats. J Toxicol Sci. 2024;49:175\u201391. https:\/\/doi.org\/10.2131\/jts.49.175.","journal-title":"J Toxicol Sci"},{"key":"10858_CR67","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW 2nd, Kitsis RN, et al. Mitochondrial function, biology, and role in disease: a scientific statement from the American Heart Association. Circ Res. 2016;118:1960\u201391. https:\/\/doi.org\/10.1161\/RES.0000000000000104.","journal-title":"Circ Res"},{"key":"10858_CR68","doi-asserted-by":"publisher","first-page":"1679085","DOI":"10.3389\/fphar.2025.1679085","volume":"16","author":"M Wang","year":"2025","unstructured":"Wang M, Li P, Chen X, Zhang Y. The crosstalk between mitochondrial dysfunction and fatty acid metabolic disturbances in the failing heart. Front Pharmacol. 2025;16:1679085. https:\/\/doi.org\/10.3389\/fphar.2025.1679085.","journal-title":"Front Pharmacol"},{"key":"10858_CR69","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/biom15111572","volume":"15","author":"N Pavlovic","year":"2025","unstructured":"Pavlovic N, Milicic D, Rainer PP. Mitochondrial dysfunction in cardiomyopathy and heart failure. Biomolecules. 2025;15:1572. https:\/\/doi.org\/10.3390\/biom15111572.","journal-title":"Biomolecules"},{"key":"10858_CR70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10557-024-07582-0","volume":"38","author":"WD Watson","year":"2024","unstructured":"Watson WD, Arvidsson HJ, O\u2019Rourke B. A mitochondrial basis for heart failure progression. Cardiovasc Drugs Ther. 2024;38:1123\u201341. https:\/\/doi.org\/10.1007\/s10557-024-07582-0.","journal-title":"Cardiovasc Drugs Ther"},{"key":"10858_CR71","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1038\/s41467-022-34559-0","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Hu L, Tao H, Huang M, Li X, Dong J, et al. Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells. Nat Commun. 2022;13:6744. https:\/\/doi.org\/10.1038\/s41467-022-34559-0.","journal-title":"Nat Commun"},{"key":"10858_CR72","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s43018-023-00577-0","volume":"4","author":"TJ Hagenbeek","year":"2023","unstructured":"Hagenbeek TJ, Webster JD, Kljavin NM, Chang MT, Pham T, Lee HJ, et al. An allosteric pan-TEAD inhibitor blocks oncogenic YAP\/TAZ signaling and overcomes KRAS inhibitor resistance. Nat Cancer. 2023;4:812\u201328. https:\/\/doi.org\/10.1038\/s43018-023-00577-0.","journal-title":"Nat Cancer"},{"key":"10858_CR73","doi-asserted-by":"publisher","first-page":"1692512","DOI":"10.3389\/fonc.2025.1692512","volume":"15","author":"R Battina","year":"2025","unstructured":"Battina R, Feng J, Gulati R, Guan KL. Targeting TEAD in cancer. Front Oncol. 2025;15:1692512. https:\/\/doi.org\/10.3389\/fonc.2025.1692512.","journal-title":"Front Oncol"},{"key":"10858_CR74","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1038\/s44319-024-00217-3","volume":"43","author":"A Kulkarni","year":"2024","unstructured":"Kulkarni A, Chang MT, Webster JD, Klijn C, Cai AG, Hongo JA, et al. Identification of resistance mechanisms to small-molecule TEAD inhibitors. Oncogene. 2024;43:2535\u201346. https:\/\/doi.org\/10.1038\/s44319-024-00217-3.","journal-title":"Oncogene"},{"key":"10858_CR75","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/cbin.70052","volume":"49","author":"A Mithaiwala","year":"2025","unstructured":"Mithaiwala A, Godad A. Exploring Hippo YAP\/TAZ signaling: a novel avenue for cardiovascular disorders. Cell Biol Int. 2025;49:1079\u2013101. https:\/\/doi.org\/10.1002\/cbin.70052.","journal-title":"Cell Biol Int"},{"key":"10858_CR76","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yjmcc.2025.08.003","volume":"207","author":"J Guan","year":"2025","unstructured":"Guan J, Del Re DP. Cell type specificity of Hippo-YAP signaling in cardiac development and disease. J Mol Cell Cardiol. 2025;207:51\u201363. https:\/\/doi.org\/10.1016\/j.yjmcc.2025.08.003.","journal-title":"J Mol Cell Cardiol"},{"key":"10858_CR77","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1152\/physiol.00003.2025","volume":"40","author":"RG Li","year":"2025","unstructured":"Li RG, Martin JF. Targeting the Hippo pathway for cardiac regeneration. Physiology. 2025;40:176\u201387. https:\/\/doi.org\/10.1152\/physiol.00003.2025.","journal-title":"Physiology"},{"key":"10858_CR78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/29780241261430920","volume":"1","author":"Y Kim","year":"2026","unstructured":"Kim Y, Lee H, Lee J, Kim W, Cha B. Hippo signaling in mechanobiology: mechanical control of YAP\/TAZ and their roles in disease. Mechanobiology. 2026;1:92. https:\/\/doi.org\/10.1177\/29780241261430920.","journal-title":"Mechanobiology"},{"key":"10858_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/cimb47050297","volume":"47","author":"JX Shen","year":"2025","unstructured":"Shen JX, Li S, Wang Y. The mechanical role of YAP\/TAZ in the development and progression of cardiovascular diseases. Curr Issues Mol Biol. 2025;47:297. https:\/\/doi.org\/10.3390\/cimb47050297.","journal-title":"Curr Issues Mol Biol"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10858-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-026-10858-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10858-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:01:21Z","timestamp":1791478881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-026-10858-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10858"],"URL":"https:\/\/doi.org\/10.1007\/s12265-026-10858-5","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}